| Literature DB >> 20157344 |
Kay M Brummond1, Jolie E Deforrest.
Abstract
Ribonuclease H (RNase H) is an essential component to the replication of human immunodeficiency virus (HIV), and only a few inhibitors of this enzyme are known. Millenia Hope Pharmaceuticals Inc. found that (-)-1,3,5-tri-O-caffeoylquinic acid is a potent RNase H inhibitor and antiviral agent. A facile route leading to this inhibitor from commercially available (-)-quinic acid is reported within.Entities:
Year: 2009 PMID: 20157344 PMCID: PMC2778492 DOI: 10.1055/S-0029-1217183
Source DB: PubMed Journal: Synlett ISSN: 0936-5214 Impact factor: 2.454